El Vínculo El Vínculo.
MałopolskieNowosądecki
Contract modification European Union Supplies

Dostawy produktów leczniczych

Szpital Specjalistyczny im. Jędrzeja Śniadeckiego

Contract modification.

Interested in tenders like this? Get the next tenders like this one published in the European Union by email. Free, no card needed.

Amounts and figures

30
Lots

Description

część nr 1: Panitumumab część nr 2: Karfilzomib część nr 3: Blinatumomab część nr 4: Romiplostym część nr 5:Denosumab część nr 6: Aflibercept część nr 7: Cemiplimab część nr 8: Triflurydyna + Typiracyl część nr 9: Kryzotynib część nr 10: Lorlatynib część nr 11: Bosutynib część nr 12: Inotuzumab ozogamycyny część nr 13 :Gemtuzumab ozogamycyny część nr 14: Ozymertynib część nr 15: Durwalumab część nr 16: Olaparyb część nr 17: Akalabrutynib część nr 18:Atezolizumab część nr 19: Alektynib część nr 20: Entrectinibum część nr 21: Trastuzumab część nr 22: Pertuzumab część nr 23: Trastuzumab emtanzyna część nr 24: Polatuzumab wedotyny część nr 25: Obinutuzumab część nr 26: Brygatynib część nr 27: Iksazomib część nr 28: Brentuksymab wedotyny część nr 29: Niraparyb część nr 30: Enzalutamid

Lots (30)

LotDescriptionCPV codeAmount
1 część nr 1: Panitumumab 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
2 część nr 2: Karfilzomib 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
3 część nr 3: Blinatumomab 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
4 część nr 4: Romiplostym 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
5 część nr 5:Denosumab 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
6 część nr 6: Aflibercept 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
7 część nr 7: Cemiplimab 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
8 część nr 8: Triflurydyna + Typiracyl 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
9 część nr 9: Kryzotynib 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
10 część nr 10: Lorlatynib 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
11 część nr 11: Bosutynib 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
12 część nr 12: Inotuzumab ozogamycyny 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
13 część nr 13 :Gemtuzumab ozogamycyny 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
14 część nr 14: Ozymertynib 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
15 część nr 15: Durwalumab 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
16 część nr 16: Olaparyb 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
17 część nr 17: Akalabrutynib 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
18 część nr 18:Atezolizumab 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
19 część nr 19: Alektynib 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
20 część nr 20: Entrectinibum 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
21 część nr 21: Trastuzumab 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
22 część nr 22: Pertuzumab 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
23 część nr 23: Trastuzumab emtanzyna 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
24 część nr 24: Polatuzumab wedotyny 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
25 część nr 25: Obinutuzumab 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
26 część nr 26: Brygatynib 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
27 część nr 27: Iksazomib 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
28 część nr 28: Brentuksymab wedotyny 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
29 część nr 29: Niraparyb 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —
30 część nr 30: Enzalutamid 33650000 General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents —

Awards

LotAwarded toAmountDate
2
część nr 2: Karfilzomib
Amgen Sp. z o.o. (Cześć 5) 718,822 zł 1 July 2024
3
część nr 3: Blinatumomab
Amgen Sp. z o.o. (Cześć 5) 562,301 zł 1 July 2024
22
część nr 22: Pertuzumab
Roche Polska Sp. z o. o. (Część 9) 647,973 zł 1 July 2024
23
część nr 23: Trastuzumab emtanzyna
Roche Polska Sp. z o. o. (Część 9) 1,024,655 zł 1 July 2024
24
część nr 24: Polatuzumab wedotyny
Roche Polska Sp. z o. o. (Część 9) 537,196 zł 1 July 2024
25
część nr 25: Obinutuzumab
Roche Polska Sp. z o. o. (Część 9) 537,196 zł 1 July 2024
26
część nr 26: Brygatynib
TAKEDA PHARMA Sp.z o.o 537,196 zł 1 July 2024
27
część nr 27: Iksazomib
TAKEDA PHARMA Sp.z o.o 537,196 zł 1 July 2024
28
część nr 28: Brentuksymab wedotyny
TAKEDA PHARMA Sp.z o.o 537,196 zł 1 July 2024
29
część nr 29: Niraparyb
GSK Services Sp. z o.o. (Część 4) 537,196 zł 1 July 2024

Modifications

  • zmiana numeru konta bankowego

Official publications

MediumReferenceDate
TED 327341-2025 21 May 2025
OJS 97/2025 21 May 2025

Other tenders from Szpital Specjalistyczny im. Jędrzeja Śniadeckiego

Previous and next from Szpital Specjalistyczny im. Jędrzeja Śniadeckiego

Similar open tenders

Frequently asked questions

Who is the buyer of this tender?
The contracting authority is Szpital Specjalistyczny im. Jędrzeja Śniadeckiego (European Union).
How can I bid for public tenders in the European Union?
Bids are submitted through the official public procurement portal in the European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.

How can I find out about similar tenders when they are published?

Create an account at el-vinculo.com and we give you a free month and set up your company's filters — contract type, CPV codes, value and territory — so you are the first to know when new tenders like this one come out in the European Union. We email you as soon as one matching your profile is published, with the whole deadline ahead to prepare the bid.

No credit card · Sign up in 2 minutes.

Get alerts for tenders like this
Create a free account and receive new public tenders published in the European Union that match your business, every day.

Start for free

Data collected from official public procurement sources. Amounts as published by the buyer.